Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 41

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04100083Phase 4Withdrawn
Spironolactone for Hidradenitis Suppurativa
Hidradenitis Suppurativa
PrincipalinvestigatorStart date: 2020-09-21
NCT04359823Phase 1Completed
DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone
Actinic Porokeratosis
PrincipalinvestigatorStart date: 2020-08-24
NCT03953209Phase 1Withdrawn
Spironolactone for the Treatment of Melasma
Melasma
PrincipalinvestigatorStart date: 2020-03-05

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Medical University of South Carolina

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04100083Phase 4PrincipalInvestigator

Spironolactone for Hidradenitis Suppurativa

Hidradenitis Suppurativa
Withdrawn
NCT04359823Phase 1PrincipalInvestigator

DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone

Actinic Porokeratosis
Completed
NCT03953209Phase 1PrincipalInvestigator

Spironolactone for the Treatment of Melasma

Melasma
Withdrawn

All 3 trials loaded